In this week’s issue:
- Alliance for Cancer Gene Therapy – 2013 Investigator Award
- Whole New World Foundation – Caplow Children’s Prize
- Leukemia & Lymphoma Society – Quest for Cures
- The Centre for Blood Research Seminar Series – “Reconstructing the evolution of HIV within a patient” (1 attachment)
- ARCC Conference 2013 – Canada’s 2nd Applied Research Conference in Cancer Control
- VCH Research Institute (VCHRI) & BC Clinical Research Infrastructure Network (BCCRIN) – 4th Clinical Research Symposium
- Canadian Bureau for International Education – Students’ Exchange Program
- BC Clinical Research Infrastructure Network (BCCRIN) – Survey (1 attachment)
LOI/Abstract Deadline: March 26, 2013
The Alliance for Cancer Gene Therapy Foundation is accepting Letters of Intent for the 2013 Investigator’s Award in Clinical Translation of Cell and Gene Therapy for Cancer. The award is designed to support production and release-testing of clinical trial agents under current good manufacturing practices, necessary pre-clinical pharmacological and toxicological studies in appropriate animal models, and/or clinical translational trials in patients in support of an Investigative New Drug application to the FDA.
The award provides up to $500,000 distributed over two to three years, inclusive of a maximum of 10 percent indirect costs.
ACGT has no citizenship restrictions, but research supported by the award must be conducted at academic medical centers located in the United States or Canada.
Deadline: May 1, 2013
The Caplow Children’s Prize, an initiative of the Miami-based Whole New World Foundation, is accepting proposals for the best plan to directly and quickly save the lives of children from birth to age 5 anywhere in the world. Proposals will be accepted from nonprofit organizations, for-profit companies, government agencies and programs, academic institutions, and individuals age 18 or older.
The prize-winner will receive $1 million to initiate the plan. The winning proposal will include a sound proposal to directly execute life-saving interventions with a high likelihood of success based on the experience and track record of the applicant. Proposals will be judged according to how many lives the plan will save, how credible the plan and the applicant are, how directly the funds can be applied, probability of success, and the ease of verification.
To enter the contest, applicants must submit an online entry form detailing the proposed project by May 1, 2013. Upon review, select applicants will receive an e-mail invitation to submit a full prize plan in June 2013. Contest finalists will be showcased in August and September 2013, with the winner to be announced at an award ceremony in December 2013.
LOI Deadline: June 3, 2013
The Leukemia & Lymphoma Society is accepting Letters of Intent from researchers for projects to identify and develop safer, more effective treatments for patients with blood cancers.
Through the Quest for Cures initiative, LLS, in partnership with biopharmaceutical company Celgene, will award two-year grants of between $200,000 and $400,000 a year for research projects that have a measurable impact over the next five to ten years on the diagnosis or treatment of patients with hematologic malignancies. Additional funding may be available for projects that have demonstrated exceptional progress in the initial two years.
Specifically, the initiative will award grants in the following priority areas:
- Tumor cell clonal heterogeneity: This grant will support researchers seeking novel approaches for measuring and monitoring clonal heterogeneity and assessing its contribution to the response or resistance to therapy.
- New molecular stratification mechanisms: Recipients of this grant will work to identify key subsets of patients with B-cell malignancies to help predict which patients will have poor outcomes from current standard therapies so they may be directed to alternative therapies.
- Bone marrow and lymph node microenvironments: Researchers will seek to enhance the understanding of the role that the bone marrow and lymph node microenvironments play in either responding to or resisting therapy.
Applicants must hold an M.D., Ph.D., or equivalent degree, and work for a domestic or foreign nonprofit organization, such as a university, a college, a hospital, or an academic laboratory. Applications may involve multiple institutions, but the applicant should have an independent research or academic position and his/her academic institution will be responsible for signing off on all terms of the grant agreement.
The Centre for Blood Research Seminar Series – “Reconstructing the evolution of HIV within a patient”
Date: March 20th, 2013 12:00pm – 1:00pm
Location: LSC 3 – Life Sciences Centre, 2350 Health Sciences Mall
Presented by Dr. Art Poon
Assistant Professor (Partner), University of British Columbia
Adjunct Assistant Professor, Simon Fraser University
Associate Research Scientist, Bioinformatics, BC Centre for Excellence in HIV/AIDS
Host: Dr. Conway
Please see the attached 03 20 13_DrPoon for abstract. Sandwiches and refreshments will be served at 11:55am.
ARCC Conference 2013 – Canada’s 2nd Applied Research Conference in Cancer Control
Date: May 27, 2013
Location: Sheraton Wall Centre, 1088 Burrard Street, Vancouver, British Columbia
Abstract Deadline: February 1, 2013
The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.
For more information please see the link above.
Date: April 23, 2013 8:30am – 4:00pm
Location: The Cordula and Günter Paetzold Health Education Centre, VGH, 855 W 12th Ave
Registration deadline: April 15, 2013
Theme: “Global Trends and Issues in Clinical Research – Think Global, Act Local”
Speaker Highlights: (Presentation titles are subject to change)
Jack Corman, President, IRB Services
Presentation: The Senate Report on Clinical Trials: Analysis and Critique. The present and future for clinical trials in Canada.
Perry Poole, Director North America- Country Clinical Operations, Head, Affiliate Process, Training and Systems (APTS) Roche/Genentech
Presentation: Global Developments in Clinical Research – implications for Canada
Dr. Anne Junker, MD, FRCP(C) Associate Professor, Pediatrics
Presentation: BCCRIN Quality Committee – Update on Current Initiatives
Jean Smart, RAP, Smart QA Services
Presentation: “Be Prepared!” Introduction to the VCHRI & BCCRIN Audit and Inspection Preparedness Program (AIPP)
Fees: $25 – Academic or Government; $50 – Industry or Private
Attendees will receive a certificate of attendance for continuing education/professional development purposes.
**lunch and refreshments provided**
Online Registration: http://www.vchri.ca/vchri-bccrin-clinical-research-symposium
*It is best to open the registration form in Google Chrome.
For questions relating to this event, please contact:
Coordinator, Research Education and Internal Awards
VCH Research Institute
Tel: (604) 875-4111 x67793
Deadline: March 29, 2013
The Government of Canada, through the Canadian Bureau for International Education (CBIE) is seeking applications from Canadian publicly funded institutions for the Students’ Exchange Program:
• Canada-CARICOM Leadership Scholarships [Caribbean, North, South & Central America]
•Emerging Leaders in the Americas [North, South & Central America, Caribbean]
• Canada-Chile Leadership Scholarships [Chile]
- • Faculty Leadership Program [see website for list of eligible countries]
*for full list of countries, see website
General Eligibility Criteria:
- These awards are available to international graduate students to undertake research or study at UBC for a period of 4 to 8 months.
- Students must be citizens of eligible countries.
- All awards are available to graduate and undergraduate students for study or research activity, with the exception of the Faculty Leadership Program, which is available only to full-time employed faculty or an international manager/administrator.
- Students coming to undertake course work must be from UBC student mobility partner institutions. For a list of UBC mobility partners, please consult the partner university search tool.
- Students coming to undertake research must be from institutions with which UBC has established research activity.
All applications must be submitted by UBC directly on behalf of the student. CBIE requires that nominations be made by UBC on behalf of the student.
Applications submitted directly by the student or home institution will not be accepted by CBIE.
Go Global plays a coordinating role on all applications submitted on behalf of the University.
Please refer to Go Global’s website for further eligibility and application details – the scholarship information and list of required documents will be updated online shortly.
Deadline to nominate and submit all application documentation for a student to Go Global is March 29, 2013. Application in full must be submitted to Go Global by this date in order to ensure that it can be considered.
Please contact Go Global at email@example.com should you have any questions.
The BC Clinical Research Infrastructure Network (BCCRIN) is conducting an on-line, anonymous survey.
To access this on-line survey, please click the link above.
For more information, please see the attached Poster